Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory disease that affects the central nervous system. It is the most common disease causing disability among young people. About 3,700 Saskatchewan people are living with MS.

Visit HealthLine Online to learn more about MS symptoms, treatment and medications.

MS Advisory Panel

Read the Multiple Sclerosis Advisory Panel Recommendations.

In July 2014, the Government of Saskatchewan appointed an 11-person advisory panel to recommend options for improving MS care, education and research in the province. Panel members included MS patients and advocates, researchers, medical specialists and a representative from the Office of Disability Issues.

The panel reviewed the status of these areas and canvassed input from people living with MS, those in health care and those involved in MS research, to identify gaps and opportunities for the future.

In February 2016, Health Minister Dustin Duncan officially received the panel's recommendations, for consideration in planning improvements in care, research and education. He also indicated that government will move forward on two recommendations: the establishment of an advisory council to generate discussion and explore options for action on degenerative neurological diseases; and the creation of a registry of Saskatchewan people diagnosed with MS, which will be a critical tool to facilitate MS research, and to monitor and improve patient care.

We need your feedback to improve Help us improve